Abstract
Severe acute respiratory sindrome - Coronavirus - 2 (SARS-CoV-2) (Coronavirus disease - 19 (COVID-19)) infection can result in long-term health consequences, such as long COVID. The clinical manifestations of long COVID include depression, anxiety, brain fog with cognitive dysfunction, memory issues, and fatigue. However, the links between vaccination and psychiatric disorders have been less studied. This article describes three patients who reported anxiety after receiving a complete course of the Pfizer-BioNTech BNT162b2 vaccine. It is important to explore the relationship between anxiety, other mental health disorders, and COVID-19 vaccination, as well as to investigate potential pathogenetic mechanisms.
| Original language | English |
|---|---|
| Article number | 1514428 |
| Journal | Frontiers in Psychiatry |
| Volume | 15 |
| DOIs | |
| Publication status | Published - 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords*
- COVID-19 vaccines
- SARS-CoV-2 vaccine
- BioNTech162 vaccine
- anxiety
- case reports
Field of Science*
- 3.2 Clinical medicine
- 3.3 Health sciences
- 3.5 Other medical sciences
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database
Fingerprint
Dive into the research topics of 'Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver